Sofina led the round with participation from Balderton Capital to support product development and market expansion.
"This round is a strong endorsement of our progress and our mission to modernise transport management. Since our Series A we’ve grown revenue, customers and team at an exceptional pace, while remaining highly capital efficient. The Series B funding allows us to continue investing and grow the team so that we can keep offering the same level of customer service."
The residential electricity provider secured the valuation following rapid customer growth and backing from investors including Lowercarbon Capital and Balderton.
The financing round was led by GV with participation from Redpoint Ventures, Balderton Capital, Point Nine, and 01A.
"CRM is one of the most important categories in B2B, but it’s been stuck in the past. AI-native CRM needs a completely different foundation — one that allows you to truly understand every customer, take action fast, and gives you the freedom to build the exact go-to-market systems you need at scale. That’s what we’re building with Attio, and this funding will allow us to accelerate our vision."
The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.
"During their time at Imperial, they worked in one of the pioneering research groups that invented modern glucose strip technology. Their combined expertise in electrochemistry, biosensing, and medical device engineering laid the foundation for Sava’s next-generation biosensor platform."
The follow-on investment was led by Lowercarbon Capital and Balderton Capital to support international growth and technology development.
"Successive cost of living crises show that our energy system is no longer fit for purpose. Affordable energy isn’t a luxury, it’s fundamental to a decent standard of living and a productive economy. At Fuse, we’re building the technology needed to realise that future"